The payer side: Patient outcomes and cost

American Journal of Therapeutics

Volumn 15, Issue SUPPL. 1, 2008, Pages

  Fish, Leslie ^a,d   Nicholson, Bruce D ^b,c  

^a Pharmacy Services   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c LEHIGH VALLEY HOSPITAL   (United States)

^d Fallon Community Health Plan   (United States)

Author keywords

Clinical outcomes; Cost(s); Opioids; OTC analgesics; Value

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; GABAPENTIN; GENERIC DRUG; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREGABALIN;

CONFERENCE PAPER; CONSTIPATION; DRUG COST; DRUG PREFERENCE; GASTROINTESTINAL TOXICITY; HEALTH INSURANCE; HUMAN; LETHARGY; NAUSEA; PAIN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; VOMITING;

ACUTE DISEASE; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC DISEASE; COSTS AND COST ANALYSIS; CYCLOOXYGENASE INHIBITORS; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MANAGED CARE PROGRAMS; PAIN; TREATMENT OUTCOME;

EID: 57649140347     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e31818bec7f     Document Type: Conference Paper

References (0)